Clinical trial
Evaluation of the VentrAssistTM Left Ventricular Assist Device for the Treatment of Advanced Heart Failure - Destination Therapy
NCT00490321 is registered in ClinicalTrials.gov with Ventracor as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the VentrAssistTM Left Ventricular Assist Device for the Treatment of Advanced Heart Failure - Destination Therapy
- Lead sponsor
- Ventracor
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- June 30, 2007
- Completion date
- June 30, 2012
- Enrollment
- 225 (estimated)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
cardiomyopathies, end-stage heart failure